PLATELET GLYCOPROTEIN IIB/IIIA MONOCLONAL-ANTIBODY (C7E3) REDUCES DISTAL EMBOLIZATION DURING PERCUTANEOUS INTERVENTION OF SAPHENOUS-VEIN GRAFTS

被引：0
|
作者：
CHALLAPALLI, RM [1 ]
EISENBERG, MJ [1 ]
SIGMON, K [1 ]
LEMBERGER, J [1 ]
机构：
[1] CLEVELAND CLIN,CLEVELAND,OH 44106
来源：
CIRCULATION | 1995年 / 92卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2908 / 2908
页数：1
相关论文
共 50 条
  • [31] Intracellular trafficking of monoclonal antibody fragment against glycoprotein IIbIIIa, c7E3 Fab, in human cultured megakaryocytes
    Perlemuter, K
    Masse, JM
    Debili, N
    Cramer, EM
    CIRCULATION, 1997, 96 (08) : 12 - 12
  • [32] COMPARATIVE EFFECTS ON PLATELET-AGGREGATION IN REAL-TIME UNDER FLOWING CONDITIONS OF IN-VIVO ASPIRIN, HEPARIN AND MONOCLONAL-ANTIBODY 7E3 AGAINST GLYCOPROTEIN-IIB-IIIA
    TURNER, NA
    MOAKE, JL
    KUMAT, S
    MCINTIRE, LV
    BLOOD, 1993, 82 (10) : A282 - A282
  • [33] Comparison of Bivalirudin Versus Bivalirudin Plus Glycoprotein IIb/IIIa Inhibitor Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitor in Patients With Acute Coronary Syndromes Having Percutaneous Intervention for Narrowed Saphenous Vein Aorto-Coronary Grafts (the ACUITY Trial Investigators)
    Kumar, Dinesh
    Dangas, George
    Mehran, Roxana
    Kirtane, Ajay
    Bertrand, Michel
    Ebrahimi, Ramin
    Guagliumi, Giulio
    Brar, Somjot
    Fahy, Martin
    Heller, Eric
    Moses, Jeffrey
    Stone, Gregg
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (07): : 941 - 945
  • [34] Platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: Differential effects with distal or proximal embolic protection in the randomized PROXIMAL trial
    Jonas, Michael
    Cox, David
    Hermiller, James
    Wahr, Joyce A.
    Massaro, Joseph
    Warh, Dennis
    Popma, Jeffrey J.
    Rogers, Campbell
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 58M - 58M
  • [35] PLATELET-RELEASE REACTION DURING EDTA-INDUCED PLATELET AGGLUTINATIONS AND INHIBITION OF EDTA-INDUCED PLATELET AGGLUTINATION BY ANTI-GLYCOPROTEIN IIB/IIIA COMPLEX MONOCLONAL-ANTIBODY
    RYO, R
    SUGANO, W
    GOTO, M
    TAKADA, M
    SAIGO, K
    HASHIMOTO, M
    YAMAGUCHI, N
    THROMBOSIS RESEARCH, 1994, 74 (03) : 265 - 272
  • [36] Pharmacokinetics, pharmacodynamics, and platelet binding of an anti-glycoprotein IIb/IIIa monoclonal antibody (7E3) in the rat: A quantitative rat model of immune thrombocytopenic purpura
    Hansen, RJ
    Balthasar, JP
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 298 (01): : 165 - 171
  • [37] STRIKING CLINICAL BENEFIT WITH PLATELET GP IIB/IIIA INHIBITION BY C7E3 AMONG PATIENTS WITH UNSTABLE ANGINA - OUTCOME IN THE EPIC TRIAL
    LINCOFF, AM
    CALIFF, RM
    ANDERSON, K
    WEISMAN, HF
    TOPOL, EJ
    CIRCULATION, 1994, 90 (04) : 21 - 21
  • [38] Glycoprotein IIb/IIIa receptor antagonist c7E3 fab and anticoagulants show an additive effect on thrombin-induced platelet aggregation after high coagulant challenge in vitro
    Köstenberger, M
    Gallistl, S
    Cvirn, G
    Roschitz, B
    Muntean, W
    30TH HEMOPHILIA SYMPOSIUM, 2001, : 369 - 377
  • [39] XV454, a novel nonpeptide small-molecule platelet GIIb/IIIa antagonist with comparable platelet αIIbβ3-binding kinetics to c7E3
    Mousa, SA
    Forsythe, M
    Bozarth, J
    Youssef, A
    Wityak, J
    Olson, R
    Sielecki, T
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 32 (05) : 736 - 744
  • [40] Direct monitoring of c7E3 and fibrinogen binding to platelets allows differentiation of GP IIb/IIIa blockade and ticlopidine effects on platelet function.
    Bode, C
    Straub, A
    Kohler, B
    Moser, M
    Ruef, J
    Nordt, T
    Peter, K
    CIRCULATION, 1998, 98 (17) : 250 - 250
12345